CIK: 1594912 - Address: 600 Montgomery Street, Suite 4500, San Francisco, CA 94111
8 results

TC

Stat

Stk

Ins

Fil

+d

+w

+m

+q

+h

+y

avg
P%ret213-2082524-413
P%wins6733673333039

Filing Date

T Date

Ticker

Issuer

Inc

Sector

Ind

Industry

Owner

oSt

Rel

Title

T

TVal

Price

L

Qty

oc

Own

H

r2y

r1y

r6m

r3m

r6w

r3w

r7d

r3d

f1d

f1w

f1m

f3m

f6m

f1y
9/6/19 20:28
9/4/19
AERIAerie Pharmaceuticals IncDEHealthBioPrdBiological Products, (No DiagForesite Capital Management Ii, LLCCATP.m2,14118.47011652,350I
9/4/19 20:38
8/30/19
AERIAerie Pharmaceuticals IncDEHealthBioPrdBiological Products, (No DiagForesite Capital Management Ii, LLCCATP.m1,57521.0007532,325I
8/23/19 20:52
8/21/19
AERIAerie Pharmaceuticals IncDEHealthBioPrdBiological Products, (No DiagForesite Capital Management Ii, LLCCATP.m1,08223.4504622,250I
8/20/19 20:27
8/16/19
AERIAerie Pharmaceuticals IncDEHealthBioPrdBiological Products, (No DiagForesite Capital Management Ii, LLCCATP.m3,67323.88015482,204I
8/14/19 20:15
8/12/19
AERIAerie Pharmaceuticals IncDEHealthBioPrdBiological Products, (No DiagForesite Capital Management Ii, LLCCATP.m13,34124.730540362,050I
7/26/16 11:10
7/22/16
AERIAerie Pharmaceuticals IncDEHealthBioPrdBiological Products, (No DiagForesite Capital Management Ii, LLCCATP4,37517.50725083,371I-19-7-98-600-21-114108137
8/26/15 16:59
8/24/15
AIMTAimmune Therapeutics, Inc.HealthDrugPharmaceutical PreparationsForesite Capital Management Ii, LLCCATP50119.65202514,443I-20-6-6-312-15-31-38
8/11/15 11:46
8/11/15
AIMTAimmune Therapeutics, Inc.HealthDrugPharmaceutical PreparationsForesite Capital Management Ii, LLCCATP.d10,34916.1233642330I05-1-19-34-43

DDerivative transaction in filing (usually option exercise)
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
AAmended filing
EError detected in filing
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top

Contact